April 15th, 2007
PT Today
Epley Omniax Feature - Relieving BPPV: The Case For Multi-Modality Collaboration
Excerpt- Cathy Epley, President
and CEO of Vesticon, a medical technology company with
several products in development related to the diagnosis and
treatment of vestibular disorders, stresses that such nuances
are why it’s critical to be focused on an accurate
diagnosis. “A definitive BPPV diagnosis will dictate
the appropriate treatment according to which canal and which
ear is affected.”
“Think of it as one of those games with the
beads that you have to get into holes by moving the
case,” Dr. Epley suggests. “You need to move the
patient to move the particles out of the canal, but first you
need to know where they are because there’s a finite
way to move the patient to move debris out of that specific
canal.”
Such
diagnostic complexity is behind Vesticon’s cutting edge
Epley Omniax™ - a multi-axial automated positioning
device affectionately referred to as “the chair.”
Currently in the final stages of testing for FDA clearance,
the Omniax comes with proprietary software that provides eye
diagnosis on three levels, monitors all ear canals in every
position, provides guidance for moving the patient and offers printable reports for
effective patient management.
“There’s a good chance you can
guess right or simply move particles for short-term
relief,” Ms. Epley notes, “but with the Epley
OmniaxTM you
can base your diagnosis on solid science rather than best
guess, and thereby enhance the patient’s chance of
quick and complete recovery.”
Go to full
story…
